ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oncology Precision Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-33A5667
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Precision Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Oncology Precision Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33A5667
Report
November 2024
Pages:158
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies
ALMAC
Angle plc
Asuragen
BGI Group
Bio Rad Laboratories
bioMérieux
Bristol–Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina Inc
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen NV

Oncology Precision Medicine - Market Size

The global market for Oncology Precision Medicine was estimated to be worth US$ 35710 million in 2023 and is forecast to a readjusted size of US$ 47750 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

Oncology Precision Medicine - Market

Oncology Precision Medicine - Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Precision Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oncology Precision Medicine by region & country, by Type, and by Application.
The Oncology Precision Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Precision Medicine.
Market Segmentation

Scope of Oncology Precision Medicine - Market Report

Report Metric Details
Report Name Oncology Precision Medicine - Market
Forecasted market size in 2030 US$ 47750 million
CAGR 4.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Applied Sciences
  • Precision Diagnostics
  • Digital Health and Information Technology
  • Precision Therapeutics
Segment by Application
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Other Cancer
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oncology Precision Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Oncology Precision Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Oncology Precision Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oncology Precision Medicine - Market size in 2030?

Ans: The Oncology Precision Medicine - Market size in 2030 will be US$ 47750 million.

Who are the main players in the Oncology Precision Medicine - Market report?

Ans: The main players in the Oncology Precision Medicine - Market are Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen

What are the Application segmentation covered in the Oncology Precision Medicine - Market report?

Ans: The Applications covered in the Oncology Precision Medicine - Market report are Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer

What are the Type segmentation covered in the Oncology Precision Medicine - Market report?

Ans: The Types covered in the Oncology Precision Medicine - Market report are Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics

1 Market Overview
1.1 Oncology Precision Medicine Product Introduction
1.2 Global Oncology Precision Medicine Market Size Forecast
1.3 Oncology Precision Medicine Market Trends & Drivers
1.3.1 Oncology Precision Medicine Industry Trends
1.3.2 Oncology Precision Medicine Market Drivers & Opportunity
1.3.3 Oncology Precision Medicine Market Challenges
1.3.4 Oncology Precision Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology Precision Medicine Players Revenue Ranking (2023)
2.2 Global Oncology Precision Medicine Revenue by Company (2019-2024)
2.3 Key Companies Oncology Precision Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oncology Precision Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Oncology Precision Medicine
2.6 Oncology Precision Medicine Market Competitive Analysis
2.6.1 Oncology Precision Medicine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oncology Precision Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Applied Sciences
3.1.2 Precision Diagnostics
3.1.3 Digital Health and Information Technology
3.1.4 Precision Therapeutics
3.2 Global Oncology Precision Medicine Sales Value by Type
3.2.1 Global Oncology Precision Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncology Precision Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Oncology Precision Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Breast Cancer
4.1.2 Lung Cancer
4.1.3 Colorectal Cancer
4.1.4 Prostate Cancer
4.1.5 Cervical Cancer
4.1.6 Other Cancer
4.2 Global Oncology Precision Medicine Sales Value by Application
4.2.1 Global Oncology Precision Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncology Precision Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Oncology Precision Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oncology Precision Medicine Sales Value by Region
5.1.1 Global Oncology Precision Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncology Precision Medicine Sales Value by Region (2019-2024)
5.1.3 Global Oncology Precision Medicine Sales Value by Region (2025-2030)
5.1.4 Global Oncology Precision Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oncology Precision Medicine Sales Value, 2019-2030
5.2.2 North America Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oncology Precision Medicine Sales Value, 2019-2030
5.3.2 Europe Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oncology Precision Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oncology Precision Medicine Sales Value, 2019-2030
5.5.2 South America Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oncology Precision Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology Precision Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncology Precision Medicine Sales Value
6.3 United States
6.3.1 United States Oncology Precision Medicine Sales Value, 2019-2030
6.3.2 United States Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncology Precision Medicine Sales Value, 2019-2030
6.4.2 Europe Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncology Precision Medicine Sales Value, 2019-2030
6.5.2 China Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncology Precision Medicine Sales Value, 2019-2030
6.6.2 Japan Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncology Precision Medicine Sales Value, 2019-2030
6.7.2 South Korea Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology Precision Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncology Precision Medicine Sales Value, 2019-2030
6.9.2 India Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncology Precision Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Oncology Precision Medicine Products, Services and Solutions
7.1.4 Abbott Laboratories Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Profile
7.2.2 Agilent Technologies Main Business
7.2.3 Agilent Technologies Oncology Precision Medicine Products, Services and Solutions
7.2.4 Agilent Technologies Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent Technologies Recent Developments
7.3 Almac
7.3.1 Almac Profile
7.3.2 Almac Main Business
7.3.3 Almac Oncology Precision Medicine Products, Services and Solutions
7.3.4 Almac Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 ANGLE plc Recent Developments
7.4 ANGLE plc
7.4.1 ANGLE plc Profile
7.4.2 ANGLE plc Main Business
7.4.3 ANGLE plc Oncology Precision Medicine Products, Services and Solutions
7.4.4 ANGLE plc Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 ANGLE plc Recent Developments
7.5 Asuragen
7.5.1 Asuragen Profile
7.5.2 Asuragen Main Business
7.5.3 Asuragen Oncology Precision Medicine Products, Services and Solutions
7.5.4 Asuragen Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Asuragen Recent Developments
7.6 BGI Group
7.6.1 BGI Group Profile
7.6.2 BGI Group Main Business
7.6.3 BGI Group Oncology Precision Medicine Products, Services and Solutions
7.6.4 BGI Group Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 BGI Group Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Oncology Precision Medicine Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 BioMérieux
7.8.1 BioMérieux Profile
7.8.2 BioMérieux Main Business
7.8.3 BioMérieux Oncology Precision Medicine Products, Services and Solutions
7.8.4 BioMérieux Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 BioMérieux Recent Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Profile
7.9.2 Bristol Myers Squibb Main Business
7.9.3 Bristol Myers Squibb Oncology Precision Medicine Products, Services and Solutions
7.9.4 Bristol Myers Squibb Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.9.5 Bristol Myers Squibb Recent Developments
7.10 Roche Holding AG
7.10.1 Roche Holding AG Profile
7.10.2 Roche Holding AG Main Business
7.10.3 Roche Holding AG Oncology Precision Medicine Products, Services and Solutions
7.10.4 Roche Holding AG Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.10.5 Roche Holding AG Recent Developments
7.11 Gilead Sciences
7.11.1 Gilead Sciences Profile
7.11.2 Gilead Sciences Main Business
7.11.3 Gilead Sciences Oncology Precision Medicine Products, Services and Solutions
7.11.4 Gilead Sciences Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.11.5 Gilead Sciences Recent Developments
7.12 Illumina
7.12.1 Illumina Profile
7.12.2 Illumina Main Business
7.12.3 Illumina Oncology Precision Medicine Products, Services and Solutions
7.12.4 Illumina Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.12.5 Illumina Recent Developments
7.13 Konica Minolta
7.13.1 Konica Minolta Profile
7.13.2 Konica Minolta Main Business
7.13.3 Konica Minolta Oncology Precision Medicine Products, Services and Solutions
7.13.4 Konica Minolta Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.13.5 Konica Minolta Recent Developments
7.14 LabCorp
7.14.1 LabCorp Profile
7.14.2 LabCorp Main Business
7.14.3 LabCorp Oncology Precision Medicine Products, Services and Solutions
7.14.4 LabCorp Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.14.5 LabCorp Recent Developments
7.15 MDxHealth
7.15.1 MDxHealth Profile
7.15.2 MDxHealth Main Business
7.15.3 MDxHealth Oncology Precision Medicine Products, Services and Solutions
7.15.4 MDxHealth Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.15.5 MDxHealth Recent Developments
7.16 Myriad Genetics
7.16.1 Myriad Genetics Profile
7.16.2 Myriad Genetics Main Business
7.16.3 Myriad Genetics Oncology Precision Medicine Products, Services and Solutions
7.16.4 Myriad Genetics Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.16.5 Myriad Genetics Recent Developments
7.17 Novartis
7.17.1 Novartis Profile
7.17.2 Novartis Main Business
7.17.3 Novartis Oncology Precision Medicine Products, Services and Solutions
7.17.4 Novartis Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.17.5 Novartis Recent Developments
7.18 OPKO Health
7.18.1 OPKO Health Profile
7.18.2 OPKO Health Main Business
7.18.3 OPKO Health Oncology Precision Medicine Products, Services and Solutions
7.18.4 OPKO Health Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.18.5 OPKO Health Recent Developments
7.19 Pacific Biosciences
7.19.1 Pacific Biosciences Profile
7.19.2 Pacific Biosciences Main Business
7.19.3 Pacific Biosciences Oncology Precision Medicine Products, Services and Solutions
7.19.4 Pacific Biosciences Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.19.5 Pacific Biosciences Recent Developments
7.20 Quest Diagnostics
7.20.1 Quest Diagnostics Profile
7.20.2 Quest Diagnostics Main Business
7.20.3 Quest Diagnostics Oncology Precision Medicine Products, Services and Solutions
7.20.4 Quest Diagnostics Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.20.5 Quest Diagnostics Recent Developments
7.21 Qiagen
7.21.1 Qiagen Profile
7.21.2 Qiagen Main Business
7.21.3 Qiagen Oncology Precision Medicine Products, Services and Solutions
7.21.4 Qiagen Oncology Precision Medicine Revenue (US$ Million) & (2019-2024)
7.21.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 Oncology Precision Medicine Industrial Chain
8.2 Oncology Precision Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology Precision Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Oncology Precision Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies
ALMAC
Angle plc
Asuragen
BGI Group
Bio Rad Laboratories
bioMérieux
Bristol–Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina Inc
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen NV
List of Tables
    Table 1. Oncology Precision Medicine Market Trends
    Table 2. Oncology Precision Medicine Market Drivers & Opportunity
    Table 3. Oncology Precision Medicine Market Challenges
    Table 4. Oncology Precision Medicine Market Restraints
    Table 5. Global Oncology Precision Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oncology Precision Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Oncology Precision Medicine Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Oncology Precision Medicine Product Type
    Table 9. Key Companies Time to Begin Mass Production of Oncology Precision Medicine
    Table 10. Global Oncology Precision Medicine Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Precision Medicine as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Oncology Precision Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Oncology Precision Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Oncology Precision Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Oncology Precision Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Oncology Precision Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Oncology Precision Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Oncology Precision Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Oncology Precision Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Oncology Precision Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Oncology Precision Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Oncology Precision Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Oncology Precision Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Oncology Precision Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Oncology Precision Medicine Sales Value by Region (2019-2024) & (%)
    Table 27. Global Oncology Precision Medicine Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Oncology Precision Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Oncology Precision Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Oncology Precision Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Oncology Precision Medicine Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Oncology Precision Medicine Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Agilent Technologies Basic Information List
    Table 37. Agilent Technologies Description and Business Overview
    Table 38. Agilent Technologies Oncology Precision Medicine Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Oncology Precision Medicine Business of Agilent Technologies (2019-2024)
    Table 40. Agilent Technologies Recent Developments
    Table 41. Almac Basic Information List
    Table 42. Almac Description and Business Overview
    Table 43. Almac Oncology Precision Medicine Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Oncology Precision Medicine Business of Almac (2019-2024)
    Table 45. Almac Recent Developments
    Table 46. ANGLE plc Basic Information List
    Table 47. ANGLE plc Description and Business Overview
    Table 48. ANGLE plc Oncology Precision Medicine Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Oncology Precision Medicine Business of ANGLE plc (2019-2024)
    Table 50. ANGLE plc Recent Developments
    Table 51. Asuragen Basic Information List
    Table 52. Asuragen Description and Business Overview
    Table 53. Asuragen Oncology Precision Medicine Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Oncology Precision Medicine Business of Asuragen (2019-2024)
    Table 55. Asuragen Recent Developments
    Table 56. BGI Group Basic Information List
    Table 57. BGI Group Description and Business Overview
    Table 58. BGI Group Oncology Precision Medicine Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Oncology Precision Medicine Business of BGI Group (2019-2024)
    Table 60. BGI Group Recent Developments
    Table 61. Bio-Rad Laboratories Basic Information List
    Table 62. Bio-Rad Laboratories Description and Business Overview
    Table 63. Bio-Rad Laboratories Oncology Precision Medicine Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Oncology Precision Medicine Business of Bio-Rad Laboratories (2019-2024)
    Table 65. Bio-Rad Laboratories Recent Developments
    Table 66. BioMérieux Basic Information List
    Table 67. BioMérieux Description and Business Overview
    Table 68. BioMérieux Oncology Precision Medicine Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Oncology Precision Medicine Business of BioMérieux (2019-2024)
    Table 70. BioMérieux Recent Developments
    Table 71. Bristol Myers Squibb Basic Information List
    Table 72. Bristol Myers Squibb Description and Business Overview
    Table 73. Bristol Myers Squibb Oncology Precision Medicine Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Oncology Precision Medicine Business of Bristol Myers Squibb (2019-2024)
    Table 75. Bristol Myers Squibb Recent Developments
    Table 76. Roche Holding AG Basic Information List
    Table 77. Roche Holding AG Description and Business Overview
    Table 78. Roche Holding AG Oncology Precision Medicine Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Oncology Precision Medicine Business of Roche Holding AG (2019-2024)
    Table 80. Roche Holding AG Recent Developments
    Table 81. Gilead Sciences Basic Information List
    Table 82. Gilead Sciences Description and Business Overview
    Table 83. Gilead Sciences Oncology Precision Medicine Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Oncology Precision Medicine Business of Gilead Sciences (2019-2024)
    Table 85. Gilead Sciences Recent Developments
    Table 86. Illumina Basic Information List
    Table 87. Illumina Description and Business Overview
    Table 88. Illumina Oncology Precision Medicine Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Oncology Precision Medicine Business of Illumina (2019-2024)
    Table 90. Illumina Recent Developments
    Table 91. Konica Minolta Basic Information List
    Table 92. Konica Minolta Description and Business Overview
    Table 93. Konica Minolta Oncology Precision Medicine Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Oncology Precision Medicine Business of Konica Minolta (2019-2024)
    Table 95. Konica Minolta Recent Developments
    Table 96. LabCorp Basic Information List
    Table 97. LabCorp Description and Business Overview
    Table 98. LabCorp Oncology Precision Medicine Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Oncology Precision Medicine Business of LabCorp (2019-2024)
    Table 100. LabCorp Recent Developments
    Table 101. MDxHealth Basic Information List
    Table 102. MDxHealth Description and Business Overview
    Table 103. MDxHealth Oncology Precision Medicine Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Oncology Precision Medicine Business of MDxHealth (2019-2024)
    Table 105. MDxHealth Recent Developments
    Table 106. Myriad Genetics Basic Information List
    Table 107. Myriad Genetics Description and Business Overview
    Table 108. Myriad Genetics Oncology Precision Medicine Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Oncology Precision Medicine Business of Myriad Genetics (2019-2024)
    Table 110. Myriad Genetics Recent Developments
    Table 111. Novartis Basic Information List
    Table 112. Novartis Description and Business Overview
    Table 113. Novartis Oncology Precision Medicine Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Oncology Precision Medicine Business of Novartis (2019-2024)
    Table 115. Novartis Recent Developments
    Table 116. OPKO Health Basic Information List
    Table 117. OPKO Health Description and Business Overview
    Table 118. OPKO Health Oncology Precision Medicine Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Oncology Precision Medicine Business of OPKO Health (2019-2024)
    Table 120. OPKO Health Recent Developments
    Table 121. Pacific Biosciences Basic Information List
    Table 122. Pacific Biosciences Description and Business Overview
    Table 123. Pacific Biosciences Oncology Precision Medicine Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Oncology Precision Medicine Business of Pacific Biosciences (2019-2024)
    Table 125. Pacific Biosciences Recent Developments
    Table 126. Quest Diagnostics Basic Information List
    Table 127. Quest Diagnostics Description and Business Overview
    Table 128. Quest Diagnostics Oncology Precision Medicine Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Oncology Precision Medicine Business of Quest Diagnostics (2019-2024)
    Table 130. Quest Diagnostics Recent Developments
    Table 131. Qiagen Basic Information List
    Table 132. Qiagen Description and Business Overview
    Table 133. Qiagen Oncology Precision Medicine Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Oncology Precision Medicine Business of Qiagen (2019-2024)
    Table 135. Qiagen Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Oncology Precision Medicine Downstream Customers
    Table 139. Oncology Precision Medicine Distributors List
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
    Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Oncology Precision Medicine Product Picture
    Figure 2. Global Oncology Precision Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oncology Precision Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Oncology Precision Medicine Report Years Considered
    Figure 5. Global Oncology Precision Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Precision Medicine Revenue in 2023
    Figure 7. Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Applied Sciences Picture
    Figure 9. Precision Diagnostics Picture
    Figure 10. Digital Health and Information Technology Picture
    Figure 11. Precision Therapeutics Picture
    Figure 12. Global Oncology Precision Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Oncology Precision Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Breast Cancer
    Figure 15. Product Picture of Lung Cancer
    Figure 16. Product Picture of Colorectal Cancer
    Figure 17. Product Picture of Prostate Cancer
    Figure 18. Product Picture of Cervical Cancer
    Figure 19. Product Picture of Other Cancer
    Figure 20. Global Oncology Precision Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Oncology Precision Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Oncology Precision Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Oncology Precision Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Oncology Precision Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Oncology Precision Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Oncology Precision Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Oncology Precision Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Oncology Precision Medicine Sales Value (%), (2019-2030)
    Figure 33. United States Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Oncology Precision Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Oncology Precision Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Oncology Precision Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 54. Oncology Precision Medicine Industrial Chain
    Figure 55. Oncology Precision Medicine Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Precision Medicine Market
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions